HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I Kohl Selected Research

HB-VAX

8/2007[Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I Kohl Research Topics

Disease

3Hepatitis A (Hepatitis, Infectious)
08/2007 - 01/2006
2Hepatitis
08/2006 - 01/2006
1Infections
08/2007
1Asymptomatic Infections
08/2006
1Hepatitis B
08/2006

Drug/Important Bio-Agent (IBA)

2VaccinesIBA
08/2007 - 01/2006
2Hepatitis A Vaccines (Hepatitis A Vaccine)IBA
08/2007 - 01/2006
2Hepatitis A AntibodiesIBA
08/2007 - 08/2006
1Engerix-BIBA
08/2007
1Combined VaccinesIBA
08/2007
1HB-VAXFDA Link
08/2007
1twinrixIBA
08/2007
1Anti-Idiotypic AntibodiesIBA
08/2006
1AntibodiesIBA
08/2006
1Hepatitis B Surface Antigens (HBsAg)FDA Link
08/2006
1Inactivated VaccinesIBA
01/2006
1Immunoglobulins (Immunoglobulin)IBA
01/2006

Therapy/Procedure

1Intramuscular Injections
01/2006